A contribution to the pharmacokinetics of some of the latest salicylate drugs
Trnavský, K.; Zachar, M.
Casopis Lekaru Ceskych 115(18): 552-555
1976
ISSN/ISBN: 0008-7335 PMID: 1277237 Document Number: 109864
Document emailed within 1 workday
Related Documents
Done, A.K. 1974: Salicylate, pharmacokinetics, and the pediatrician Pediatrics 54(6): 670-672Dean, M.; Penglis, S.; Stock, B. 1989: The pharmacokinetics of salicylate in the pregnant Wistar rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(1): 87-90
Morris, M.E. 1990: Pharmacokinetics and protein binding of salicylate metabolites in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 809-811
Comar, O.B.; Di Rienzo, A. 1988: Latest contribution concerning the use of mepartricin in adenoma of the prostate Minerva Urologica e Nefrologica 40(2 Suppl): 30-32
Yu, H.Y.; Shen, Y.Z.; Sugiyama, Y.; Hanano, M. 1990: Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(1): 121-126
Dubb, J.W.; Stote, R.M.; Maass, A.R.; Hwang, B.V.; Familiar, R.G.; Alexander, F. 1979: Tienilic acid: pharmacokinetics, salicylate interaction and creatinine secretion studies Postgraduate Medical Journal 55(Suppl 3): 47-57
Kalhan, V.; Sadick, N. 2017: The Latest Drugs and Small Molecule Inhibitors for Skin and Hair Journal of Drugs in Dermatology: Jdd 16(12): 1224-1228
Novikov, S.M.; Melńikova, N.N.; Neriueva, V.V.; Semenovykh, L.N.; Murkova, M.V. 1994: Hygienic standardization of methyl salicylate and isoamyl salicylate in the atmospheric air of populated areas Gigiena i Sanitariia 1: 4-5
Brick, D.L.; Corrigan, A.B. 1970: Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations Medical Journal of Australia 2(8): 382-383
Galloro, V. 2009: Mixing drugs. Latest pharma deals unlikely to affect prices: experts Modern Healthcare 39(11): 14
Hill, J.B. 1971: Experimental salicylate poisoning: observations on the effects of altering blood pH on tissue and plasma salicylate concentrations Pediatrics 47(4): 658-665
Kock-Weser, J. 1975: Pharmacokinetics of antiarrhythmic drugs Cardiovascular Clinics 7(2): 191-202
Bernareggi, A. 1995: Pharmacokinetics of chiral drugs Bollettino Chimico Farmaceutico 134(2): 63-68
Banditt, P.; Meyer, F.P.; Walther, H. 1990: The effect of cimetidine on pharmacokinetics of other drugs Die Pharmazie 45(1): 11-16
Orme, M.; Edwards, G.; Awadzi, K.; Breckenridge, A. 1990: Clinical pharmacokinetics of drugs against onchocerciasis Acta Leidensia 59(1-2): 329-342
Franc, Z.; Smolik, S.; Horesovský, O.; Hfadil, F. 1976: Biochemistry of drugs XXII. Pharmacokinetics of noroxyclothepine Ceskoslovenska Farmacie 25(7): 227-231
Sams, R.A. 1984: Principles of clinical pharmacokinetics of antimicrobial drugs Journal of the American Veterinary Medical Association 185(10): 1068-1071
Hankiss, János. 2004: Contribution to the discussion about antihypertensive drugs Orvosi Hetilap 145(36): 1874-5; author reply 1875
Rylance, G. 1984: Pharmacokinetics of anticonvulsant drugs and their dosage in childhood epilepsy Recenti Progressi in Medicina 75(1): 51-65
Van der Kleijn, E.; Baars, A.M.; Vree, T.B.; van der Dries, A. 1983: Clinical pharmacokinetics of drugs used in the treatment of status epilepticus Advances in Neurology 34: 421-440